Autolus Therapeutics (AUTL) Earnings Date & Reports

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUTL is expected to report earnings to rise 6.67% to -15 cents per share on October 29

Autolus Therapeutics AUTL Stock Earnings Reports

Q3'26

Est.

$-0.16

Q2'26

Beat

by $0.08

Q1'26

Missed

by $0.02

Q4'25

Missed

by $0.09

Q3'25

Missed

by $0.08

The last earnings report on August 11 showed earnings per share of -15 cents, beating the estimate of -23 cents. With 1.14M shares outstanding, the current market capitalization sits at 500.39M.

View a ticker or compare two or three

AUTL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for AUTL